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Abstract
Cannabidiol (CBD), a major nonpsychotropic cannabinoid found in Cannabis plant, has been shown to influence cardiovascular functions under various physiological and pathological conditions. In the present study, the effects of CBD on contractility and electrophysiological properties of rat ventricular myocytes were investigated. Video edge detection was used to measure myocyte shortening.
Intracellular Ca 2+ was measured in cells loaded with the Ca 2+ sensitive fluorescent indicator fura-2 AM.
Whole-cell patch clamp was used to measure action potential and Ca 2+ currents. Radioligand binding was employed to study pharmacological characteristics of CBD binding. CBD (1 μM) caused a significant decrease in the amplitudes of electrically-evoked myocyte shortening and Ca 2+ transients.
However, the amplitudes of caffeine-evoked Ca 2+ transients and the rate of recovery of electricallyevoked Ca 2+ transients following caffeine application were not altered. Whole-cell patch-clamp technique was employed to investigate the effect of CBD on the characteristics of action potentials (APs) and L-type Ca 2+ channels. CBD (1 μM) significantly decreased the duration of APs. Further studies on L-type Ca 2+ channels indicated that CBD inhibits these channels with IC 50 of 0.1 µM in a voltage-independent manner. Radioligand studies indicated that the specific binding of [ 3 H]Isradipine, was not altered significantly by CBD. The results suggest that CBD depresses myocyte contractility by suppressing L-type Ca 2+ channels at a site different than dihydropyridine binding site and inhibits excitation-contraction coupling in cardiomyocytes.
Introduction
Cannabidiol (CBD) is a major nonpsychoactive phytocannabinoid found in Cannabis sativa.
Although it is devoid of psychoactive properties, in earlier studies CBD has been shown to possess anti-apoptotic, anti-oxidant, and anti-inflammatory effects [for reviews, 1, 2]. Interestingly, CBD displays low affinity for the cannabinoid CB 1 and CB 2 receptors [for reviews, 3, 4] . Thus, pharmacological actions of CBD have been suggested to be mediated mainly by its direct actions on various enzymes and ion channels or through a novel cannabinoid (non-CB 1 and non-CB 2 ) receptor [for reviews, 3, 4] .
Several earlier studies indicate that CBD has beneficial effects in various cardiovascular pathologies such as myocardial infarction, ischemia-induced arrhythmias, and diabetic cardiomyopathy [5, 6, 7, 8] . Although anti-oxidant and anti-inflammatory actions have been suggested to be involved in these beneficial effects [9] , the exact mechanisms of CBD actions are currently unknown.
Haeomodynamic effects of CBD have been investigated in earlier in vivo and in vitro studies [10] . In pentobarbitone anaesthetized rats, CBD has been shown to cause a significant but transient fall in mean arterial blood pressure [6] . Similarly, in arterial segments taken from rat mesenteric vascular bed that have been pre-constricted with phenylephrine, CBD has been shown to cause a concentrationdependent vasorelaxation [11] . Likewise, in rat isolated aortae, application of CBD (1-30 µM) caused vasorelaxation. In agreement with these findings, in human mesenteric arteries, it has been shown that CBD causes vasorelaxation of endothelin-1 pre-constricted arterial segments [12] . In these studies, both cannabinoid receptor-dependent and independent mechanisms have been shown to play roles in CBD inhibition of smooth muscle contraction. Further contributions to the complexity of CBD actions include the type of vascular structure, the presence of intact endothelium, the metabolic products of A c c e p t e d M a n u s c r i p t 5 endocannabinoids [13] and the activity of metabolizing enzymes have also been shown to modulate the actions of CBD on cardiovascular system [10] .
Compared with the information available on the vascular effects of CBD, to our knowledge, there have been few studies focusing on the role of CBD in the regulation of contractility and Ca
2+
signaling in cardiac muscle. In earlier in vitro studies, negative inotropic and bradycardic effects of CBD have been reported [14] . In addition, in perfused rat heart, CBD has been shown to antagonize the Δ 9 -tetrahydrocannabinoid-induced positive inotropic effect and tachycardia, one of the most consistent cardiovascular effects of Cannabis intoxication [15] . In the present study, we have hypothesized that the negative inotropic actions of CBD observed in earlier studies are due to the inhibition of excitationcontraction coupling in ventricular myocytes. Thus, we have investigated the effects of CBD on contractility and electrical properties of acutely dissociated rat ventricular myocytes.
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Materials and Methods

Ventricular myocyte isolation
Ventricular myocytes were isolated from adult male Wistar rats (248 ± 17 g) according to previously described techniques [16] . This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the UAE University. Briefly, the animals were euthanized using a guillotine and hearts were removed rapidly and mounted for retrograde perfusion according to the Langendorff method. Hearts were perfused at a constant flow of 8 ml g heart -1 min -1 and at 36-37 ˚C with a solution containing (mM): 130 NaCl, 5. 
Measurement of intracellular Ca 2+ concentration
Myocytes were loaded with the fluorescent indicator fura-2 AM (F-1221, Molecular Probes, USA) as described previously [17] . In brief, 6.25 µl of a 1 mM stock solution of fura-2 AM (dissolved in dimethylsulphoxide) was added to 2.5 ml of cells to give a final fura-2 concentration of 2.5 µM.
Myocytes were shaken gently for 10 min at 24 ˚C (room temperature). After loading, myocytes were 
Measurements of sarcoplasmic reticulum Ca 2+ content
Sarcoplasmic reticulum (SR) Ca 2+ release was assessed using previously described techniques [18] . After establishing steady state Ca 2+ transients in electrically stimulated (1 Hz) myocytes maintained at 35-36˚C and loaded with fura-2, stimulation was paused for a period of 5 s. Caffeine (20 mM) was then applied for 10 s using a solution switching device customized for rapid solution 
Assessment of myofilament sensitivity to Ca
2+
In some cells shortening and fura-2 ratio were recorded simultaneously. Myofilament sensitivity to Ca 2+ was assessed from phase-plane diagrams of fura-2 ratio vs. cell length by measuring the gradient of the fura-2-cell length trajectory during late relaxation of the twitch contraction. The position of the trajectory reflects the relative myofilament response to Ca 2+ and hence, was used as a measure of myofilament sensitivity to Ca 2+ [19] .
Electrophysiological measurements of action potentials
Action potentials (APs) were measured using whole-cell patch clamp technique. Recordings 
Radioligand binding studies with [ 3 H]Isradipine
Experiments on the binding of [ 3 H]Isradipine (Specific activity 58.6 Ci /mmol, New England Nuclear, Chadds Ford, PA, USA) were conducted similar to our earlier studies [20] . Briefly, aliquots of membranes (0.1 mg) were added to different concentrations of radiolabeled ligand to give a final concentration of 0.02 mg/ml membranes in a total volume of 0.8 ml. After 60 min incubation at room temperature, 0.4 ml aliquots of each sample were filtered under vacuum through Watman GF\C filters and rapidly washed with 5 ml of ice-cold assay buffer. The filters were dried and extracted in 5 ml of (Fig. 1D) .
M a n u s c r i p t The effects of CBD on myofilament sensitivity to Ca 2+ were also investigated. These experiments tested whether CBD decreases the mechanical responses by altering the affinity of the contractile machinery of the ventricular myocytes to intracellular Ca 2+ . Typical record of myocyte shortening, fura-2 ratio and phase-plane diagrams of fura-2 ratio vs. cell length in myocytes exposed to NT are shown in Fig. 4A . The gradient of the trajectory reflects the relative myofilament response to Ca 2+ and hence, has been used as a measure of myofilament sensitivity to Ca 2+ [19] . The gradients of the fura-2-cell length trajectory during late relaxation of the twitch contraction measured during the periods 500-600 ms (Fig. 4B) , 500-700 ms (Fig. 4C) , and 500-800 ms (Fig. 4D) were not significantly altered in CBD compared to NT suggesting that myofilament sensitivity to Ca 2+ is not reduced by CBD (CBD-treatment was compared to NT containing 0.02 % DMSO, paired t-test; n = 17 cells; P>0.05).
Effects of cannabidiol on the action potentials of ventricular myocytes
In this set of experiments, patch-clamped cardiomyocytes were exposed to the CBD while continuously monitoring their V rest and APs in the current clamp mode. The generation of APs was evoked by 0.9-1 nA depolarizing current pulses of 4 ms duration. Since the intracellular pipette solution did not contain Ca 2+ -chelating agents, the generation of each AP was accompanied by myocyte contraction. Therefore, current pulses were applied at a frequency of 0. M a n u s c r i p t
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Effects of cannabidiol on L-type Ca 2+ currents
We have also investigated the effect of CBD (1 µM) on the L-type Ca 2+ currents (I L,Ca ). Figure   6A shows a typical record of I L,Ca elicited by applying a single 300 ms voltage pulse to +10 mV from a holding potential of -50 mV in rat ventricular myocyte before and after 10 min superfusion with 1 µM CBD. Time course of the effect of CBD on the density of I L,Ca was presented in Figure 6B . Elimination of contaminating Na + current during recording of I L,Ca was achieved by applying voltage step-pulses from relatively depolarized V h of -50 mV, which produced steady-state inactivation of sodium channels [21] . As evident from original recordings and I-V relationships (Fig. C, D (Fig. 7C) .
Effects of CBD on [ 3 H]Isradipine binding
It was possible that CBD interacts directly with the binding site of dihydropyridine class of Ca M a n u s c r i p t 17
Discussion
The results of this study indicate for the first time that inhibition of Ca 2+ signaling underlies the negative inotropic actions of CBD in rat ventricular myocytes and that the inhibition of L-type Ca 2+ channel mediates the effects of CBD on myocyte contractility.
Administration of cannabinoids, such as THC and CBD, causes complex hemodynamic changes involving phases of both increased and decreased blood pressure as well as changes in heart rate and contractility [for reviews , 10, 23] . CBD has been shown to have various effects on muscular structures, neuronal and endothelial cells and alter the activities of several receptors, ion channels [for reviews, 3, 9, 24] and neurotransmitter transporters [24, 25] . However, using video edge detection system allows measurement of contractility at single-cell level in a relatively isolated environment and excludes the influence of autonomic nerve endings, gap-junctions, neurotransmitter uptake system, and coronary perfusion status. In our experiments, CBD caused a significant reduction in the maximal shortening amplitudes without significantly altering the time course of myocyte contraction. These findings provide evidence that the negative inotropic effect of CBD reported in earlier studies [14, 15] results from a direct interaction of CBD with ventricular myocytes, rather than actions of CBD on nerve endings and neurotransmitter uptake systems in the heart. CBD has been shown to have antagonist effects on GPR55 [27] . Therefore antagonism of a constitutive GPR55 activity can mimic the actions of CBD on the contractility of cardiomyocytes.
However, AM251, an agonist of GPR55 and antagonist/inverse agonist of CB1 receptor, does not alter the contractility of cardiomyocytes and amplitudes of L-type Ca 2+ currents [28, 29] suggesting that antagonism of GPR55 receptors does not mediate the effects of CBD in cardiomyocytes. In several recent studies, activation of peroxisome proliferator-activated receptor gamma (PPARγ) has been
shown to mediate the effects of CBD [13, 30] . However, PPARγ antagonist, GW9662 (1 µM, [13] ), did not reverse the effects of CBD on myocyte shortening (data not shown).
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Negative inotropic actions of CBD might be attributed to the inhibition of Ca 2+ release from the SR. In fact, CBD and other cannabinoids have been reported to modulate the ryanodine sensitive intracellular Ca 2+ stores in neurons [9, 31] . However, the amplitude and kinetics of caffeine-induced Ca 2+ release from intracellular Ca 2+ stores were not changed by CBD suggesting that ryanodinesensitive intracellular Ca 2+ stores are not involved in negative inotropic effects of CBD observed in this study. CBD can alter the levels of second messengers such as cAMP, cGMP and protein kinase C which are known to be involved in tuning the Ca 2+ sensitivity of the contractile proteins. In an earlier study in cardiac muscle membranes, cAMP levels have been shown to be unaltered in the presence of CBD [32] . Furthermore, sensitivity of contractile proteins to intracellular Ca 2+ remained unchanged in the presence of CBD suggesting that phosphorylation and de-phosphorylation of the contractile proteins do not play a significant role in negative inotropic actions of CBD. Collectively, these results suggest that the effects of CBD on myocyte contractility are not related to changes in intracellular Ca 2+ release machinery or sensitivity of myofilaments to Ca 2+ . In addition, in the presence of CBD, resting levels of intracellular Ca 2+ and cell length of ventricular myocytes remained unaltered suggesting that CBD does not significantly affect Ca 2+ homeostasis under resting conditions.
During excitation-contraction coupling, alterations in the amplitudes and kinetics of cardiac AP are closely associated with corresponding changes in the contractility of myocytes [33] . In our study, In clinical studies, acute CBD intake does not cause a significant change in blood pressure and heart rate [for a review, 10]. However, several earlier studies indicate that the increases in blood pressure and heart rate during stressful conditions are markedly attenuated by CBD [34, 35, 36] . In in vivo studies, increased heart rate and blood pressure, two of the most consistent effects of Cannabis intoxication, are also decreased by CBD [15] . Collectively these results suggest that CBD, at relatively high concentrations, can suppress the function of cardiovascular system. In fact, cardiac failure due to depressed heart contractility has been suggested to be the main cause of mortality in Cannabis intoxication [for a review, 37]. Thus it is likely that some of the effects of Cannabis plant are mediated by CBD during Cannabis intoxication.
In addition to cardiac contractility, the electrical activity of the heart has also been suggested to be affected by CBD. In an earlier study, CBD has been shown to have beneficial actions in ischemiainduced cardiac arrhythmias [6] . Shortening of AP duration by CBD observed in our study can be beneficial or harmful, depending on the underlying pathology. Thus, during acute ischemia, in which M a n u s c r i p t M a n u s c r i p t 
